Phage therapy in a lung transplant recipient with cystic fibrosis infected with multidrug‐resistant Burkholderia multivorans

Considerations for the Use of Phage Therapy in Clinical Practice

(2022) Gina A. Suh et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The effects of different doses of inhaled bacteriophage therapy for Pseudomonas aeruginosa pulmonary infections in mice

(2022) Rachel Yoon Kyung Chang et al.   CLINICAL MICROBIOLOGY AND INFECTION

Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review

(2022) Saartje Uyttebroek et al.   LANCET INFECTIOUS DISEASES

Bacteriophage treatment of disseminated cutaneous Mycobacterium chelonae infection

(2022) Jessica S. Little et al.   Nature Communications

Nebulized bacteriophage in a patient with refractory Mycobacterium abscessus lung disease

(2022) Rebekah M. Dedrick et al.   Open Forum Infectious Diseases

Genomic characterization of lytic bacteriophages targeting genetically diverse Pseudomonas aeruginosa clinical isolates

(2022) Hayley R. Nordstrom et al.   iScience

Benefits of aerosolized phages for the treatment of pneumonia due to methicillin-resistant Staphylococcus aureus (MRSA): an experimental study in rats

(2021) Josef Prazak et al.   JOURNAL OF INFECTIOUS DISEASES

Pre-optimized phage therapy on secondary Acinetobacter baumannii infection in four critical COVID-19 patients

(2021) Nannan Wu et al.   Emerging Microbes & Infections

Potent antibody-mediated neutralization limits bacteriophage treatment of a pulmonary Mycobacterium abscessus infection

(2021) Rebekah M. Dedrick et al.   NATURE MEDICINE

Early clinical experience of bacteriophage therapy in 3 lung transplant recipients

(2019) Saima Aslam et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Use of ceftazidime/avibactam for the treatment of MDR Pseudomonas aeruginosa and Burkholderia cepacia complex infections in cystic fibrosis: a case series

(2018) G Spoletini et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The potential of phage therapy in cystic fibrosis: Essential human-bacterial-phage interactions and delivery considerations for use in Pseudomonas aeruginosa -infected airways

(2017) Stephanie Trend et al.   Journal of Cystic Fibrosis

Anti-Tuberculosis Bacteriophage D29 Delivery with a Vibrating Mesh Nebulizer, Jet Nebulizer, and Soft Mist Inhaler

(2017) Nicholas B. Carrigy et al.   PHARMACEUTICAL RESEARCH

Long-Term Evolution of Burkholderia multivorans during a Chronic Cystic Fibrosis Infection Reveals Shifting Forces of Selection

(2016) Inês N. Silva et al.   mSystems

Phage Neutralization by Sera of Patients Receiving Phage Therapy

(2014) Marzanna Łusiak-Szelachowska et al.   VIRAL IMMUNOLOGY

Impact ofBurkholderiaInfection on Lung Transplantation in Cystic Fibrosis

(2008) Susan Murray et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE